Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -53.27% vs 31.81% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -48.39% vs 11.21% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -59.48% vs 24.84% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 5.00% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Tibet Rhodiola Pharmaceutical Holding Co. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -53.27% vs 31.81% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -21.78% vs 2.35% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -48.39% vs 11.21% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -8.28% vs -35.87% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -59.48% vs 24.84% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -30.35% vs 11.94% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 5.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -47.50% vs -2.44% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






